Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oxaceprol (N-Acetyl-L-hydroxyproline) is an established therapeutic agent for osteoarthritis.
説明 | Oxaceprol (N-Acetyl-L-hydroxyproline) is an established therapeutic agent for osteoarthritis. |
In vivo | Oxaceprol, an established therapeutic agent for osteoarthritis, had no effect on macrophage prostaglandin E2 release in vitro and inhibited carrageenan paw oedema at high doses (18-150 mg/kg p.o.).?In the same dose range, oxaceprol was comparable to indomethacin (3 mg/kg p.o.) as an inhibitor of yeast hyperalgaesia and at 6-50 mg/kg/day p.o. had a mild, variable inhibitory effect on cotton pellet granuloma formation[1] |
別名 | N-Acetyl-L-hydroxyproline |
分子量 | 173.17 |
分子式 | C7H11NO4 |
CAS No. | 33996-33-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (577.47 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Oxaceprol 33996-33-7 Others osteoarthritis inhibit N-Acetyl-L-hydroxyproline arthritis anti-inflammatory rheumatoid Inhibitor antirheumatic inhibitor